PharmaceuticalCompanies
List your company
CompaniesCDMOsAPIGeographyShortagesPatent cliff
Register entry

BRACCO DIAGNOSTICS INC

Request a quoteClaim this profile
Registered sites
6
Drug products
31
Live patents
3
Countries
4
Base
Italy
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites

Facilities

6
SiteLocationOperationsFEI
Bracco Suisse SAPlan-les-OuatesSwitzerlandAnalytical testing, Finished drug manufacture3002740213
BIPSO GmbHSingen (Hohentwiel)GermanyAnalytical testing, Finished drug manufacture3009099058
BRACCO IMAGING SPACOLLERETTO GIACOSAItalyAnalytical testing, Finished drug manufacture3005604782
BRACCO IMAGING SPACeriano LaghettoItalyAnalytical testing, Active ingredient (API) manufacture1000171506
SPIN S.p.A.TorviscosaItalyActive ingredient (API) manufacture3019100570
BRACCO DIAGNOSTICS INCPrinceton, NJUnited StatesFinished drug manufacture1000307800
Exclusivity

Patents

3

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
LUMASONSULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERESJul 2038
LUMASONSULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERESMay 2039
Catalogue

Marketed products

31

Showing 31 of 31.

BrandGeneric nameFormCategory
CardioGen-82Rubidium Chloride RB-82INJECTION, SOLUTIONNDA
CholetecMebrofeninINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
Cystografindiatrizoate meglumineINJECTION, SOLUTIONNDA
Cystografin Dilutediatrizoate meglumineINJECTION, SOLUTIONNDA
Gastrografindiatrizoate meglumine and diatrizoate sodiumLIQUIDNDA
IOMERVUIomeprol InjectionINJECTION, SOLUTIONNDA
IOMERVUIomeprol InjectionINJECTION, SOLUTIONNDA
ISOVUE 200IOPAMIDOLINJECTION, SOLUTIONNDA
ISOVUE 250IOPAMIDOLINJECTION, SOLUTIONNDA
ISOVUE 300IOPAMIDOLINJECTION, SOLUTIONNDA
ISOVUE 370IOPAMIDOLINJECTION, SOLUTIONNDA
ISOVUE-MIOPAMIDOLINJECTION, SOLUTIONNDA
ISOVUE-MIOPAMIDOLINJECTION, SOLUTIONNDA
IomeronIomeprol InjectionINJECTION, SOLUTIONUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol InjectionINJECTION, SOLUTIONUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol InjectionINJECTION, SOLUTIONUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol InjectionINJECTION, SOLUTIONUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol InjectionINJECTION, SOLUTIONUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol InjectionINJECTION, SOLUTIONUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol InjectionINJECTION, SOLUTIONUNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
KINEVACsincalideINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONNDA
LumaSonSULFUR HEXAFLUORIDEKITNDA
LumasonSULFUR HEXAFLUORIDEINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSIONNDA
MultiHancegadobenate dimeglumineINJECTION, SOLUTIONNDA
MultiHancegadobenate dimeglumineINJECTION, SOLUTIONNDA
ProHancegadoteridolINJECTION, SOLUTIONNDA
VuewayGadopiclenolINJECTIONNDA
VuewayGadopiclenolINJECTIONNDA
VuewayGadopiclenolINJECTIONNDA
VuewayGadopiclenolINJECTIONNDA
VuewayGadopiclenolINJECTIONNDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.